Search results
Results From The WOW.Com Content Network
Ribonucleotide reductase and DNA polymerase inhibitor. [11] Acute lymphoblastic leukaemia and acute myeloid leukaemia: Myelosuppression, hypokalaemia, cytokine release syndrome, Stevens–Johnson syndrome (uncommon), toxic epidermal necrolysis (uncommon) and pancreatitis (uncommon) Cytarabine: SC, IM, IV, IT: DNA polymerase inhibitor, S-phase ...
This list is organized by type of agent, although the subsections are not necessarily definitive and are subject to revision. Each drug is listed once (at present), though it might fall in more than one subsection. A full alphabetical listing is included after the categorical listing.
Download as PDF; Printable version; In other projects Wikidata item; ... Pages in category "CYP1A2 inhibitors" The following 15 pages are in this category, out of 15 ...
Download QR code; Print/export Download as PDF; Printable version; In other projects Wikimedia Commons; ... Template:Enzyme inhibition; Enzyme modulator; 2 ...
Suplatast tosilate is an inhibitor of cytokine T helper cells. [1] Overstimulation of these T h 2 cells can lead to an allergic reaction, [2] so the drug is used as an antihistamine. [3] It has also been used in the treatment of Kimura's disease. [4] [5]
Download as PDF; Printable version; In other projects Wikimedia Commons; Wikidata item; Appearance. move to sidebar hide. Help ... Pages in category "CYP3A4 inhibitors"
Interleukin 10 (IL-10), also known as human cytokine synthesis inhibitory factor (CSIF), is an anti-inflammatory cytokine. In humans, interleukin 10 is encoded by the IL10 gene. [ 5 ] IL-10 signals through a receptor complex consisting of two IL-10 receptor-1 and two IL-10 receptor-2 proteins. [ 6 ]
The thalidomide molecule is a synthetic derivative of glutamic acid and consists of a glutarimide ring and a phthaloyl ring (Figure 5). [15] [16] Its IUPAC name is 2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione and it has one chiral center [15] After thalidomide's selective inhibition of TNF-α had been reported, a renewed effort was put in thalidomide's clinical development.